Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Deaths After Back Surgery Are Often Related to Analgesics

By HospiMedica International staff writers
Posted on 29 Apr 2009
Close to 20% of deaths following lumbar fusion surgery are related to analgesic use, according to a new study. More...


Researchers from the University of Washington (Seattle, USA) conducted a retrospective population-based cohort study and analyzed workers' compensation claims filed by lumbar fusion patients between 1994 and 2001. The researchers assessed the frequency, timing, and causes of death, which was ascertained from Washington State vital statistics records and from the workers' compensation claims database. Poisson regression was used to obtain age- and gender-adjusted mortality rates; years of potential life lost, percent of potential life lost, and mean potential life lost were calculated for the leading 5 causes of death and the risk of death was calculated in association with selected predictors.

The study results showed that among the 2,378 lumbar fusion subjects in the study cohort, 103 were deceased by 2004. The 3-year cumulative mortality rate was 1.93%, while the 90-day perioperative mortality rate was 0.29%. The age- and gender-adjusted all-cause mortality rate was 3.1 deaths per 1000 worker-years. There were 22 analgesic-associated deaths (19 accidental poisonings and 3 suicides). These accounted for 21% of all deaths and for 31.4% of all potential life lost. The researchers also found that the use of instrumentation or intervertebral cage devices for fusion, and the presence of degenerative disc disease were both risk factors for analgesic-related death. In fact, in subjects between 45 and 54 years of age, degenerative disc disease increased the odds of analgesic-related death by 7.45-fold. Repeat fusions were found to predict perioperative mortality. The study was published in the April 1, 2009, issue of Spine.

"The most important finding of this study was that analgesic-related deaths, both suicidal and accidental, claimed the highest potential life lost, more than heart disease (9.2%), cancer (9.1%), and liver disease (5.1%), combined," concluded lead author Sham Maghout Juratli, M.D., and colleagues of the division of occupational and environmental medicine.

Related Links:

University of Washington



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.